Free Trial
CVE:LTY

Liberty Biopharma (LTY) Stock Price, News & Analysis

Liberty Biopharma logo
C$2.00 +2.00 (+∞)
As of 10/10/2018

About Liberty Biopharma Stock (CVE:LTY)

Key Stats

Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Redhill Biopharma Ltd ADR
See More Headlines

LTY Stock Analysis - Frequently Asked Questions

Liberty Biopharma's stock was trading at C$2.00 at the start of the year. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2025 here
.

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liberty Biopharma investors own include Barrick Gold (GOLD), Aecon Group (AEGXF), Adial Pharmaceuticals (ADIL), Adeia (ADEA), Acurx Pharmaceuticals (ACXP), AC Immune (ACIU) and Air Canada (AC).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:LTY
Previous Symbol
CVE:VVA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
2,000.00
Book Value
C$0.79 per share
Price / Book
2.53

Miscellaneous

Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (CVE:LTY) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners